Home  >  News
Eppen_epTIPS_Jun2026
you can get e-magazine links on WhatsApp. Click here
News
  Glenmark Pharma arm launches Winlevi in key European markets,   June 11, 2026
  Bayer announces EMA confirms asundexian MAA for assessment in secondary prevention of ischemic stroke,   June 11, 2026
  Lupin collaborates with LABORATORIOS ERN to launch Luforbec pMDI in Spain,   June 08, 2026
  Gilead applauds collaborative efforts to launch lenacapavir for HIV prevention in South Africa,   June 06, 2026
  Teva Pharma launches aflibercept biosimilar in Europe,   June 06, 2026
  UK MHRA grants marketing approval to Madrigal Pharmaceuticals’ resmetirom to treat metabolic dysfunction-associated steatohepatitis in adults,   June 05, 2026
  Glenmark Pharma launches lacosamide injection USP, 200 mg/20 mL (10 mg/mL), single-dose vials,   June 05, 2026
  Novo Nordisk launches obesity drug Wegovy in UAE,   June 04, 2026
  Alkem Labs launches semaglutide in single-shot pre-filled syringes at price starting Rs. 350,   June 03, 2026
  UK MHRA grants marketing authorization to Sanofi’s rilzabrutinib to treat adults with immune thrombocytopenia when prior treatments have been insufficient,   June 01, 2026
  Merz Therapeutics and Jiangxi Kvvit Pharma ink exclusive agreement for Inbrija in mainland China, Hong Kong & Macao,   May 29, 2026
  Pharming’s Joenja receives European marketing authorization for the treatment of activated PI3K delta syndrome,   May 26, 2026
  EMA grants conditional marketing authorization to Novartis Europharm’s Vijoice to treat rare uncontrolled growth of body tissues,   May 25, 2026
  EMA committee recommends marketing approval for Boehringer Ingelheim’s Jascayd to treat IPF and progressive pulmonary fibrosis,   May 25, 2026
  Hanmi Pharmaceutical inks supply agreement with Organon to export combination therapies to Southeast Asia,   May 23, 2026
  Lupin receives Chinese approval for oseltamivir phosphate oral suspension,   May 23, 2026
  Chinese NMPA grants marketing authorization for a label extension to Bayer’s Kerendia to treat adult patients with heart failure with LVEF =40%,   May 23, 2026
  Samsung Bioepis introduces ustekinumab biosimilar,   May 21, 2026
  Dr Reddy’s Labs launches oral semaglutide biosimilar ‘Obeda’ tablets in India,   May 20, 2026
  Glenmark Pharma introduces vancomycin hydrochloride for injection USP, 500 mg/vial and 1 g/vial,   May 18, 2026

 Back
 
Propak_Asia_2026
APME-2026.gif
echemi_logo26
PPPE_2026
cphi_korea2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram